Early Donor T-Cell Engraftment Is Critical for Immune Tolerance in Reduced Intensity Haploidentical Bone Marrow Transplant with Post-Transplant Cyclophosphamide for Sickle Cell Disease: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC2)

Autor:	Connelly, Jim A., Biltibo, Eden, Wilkerson, Karina *, Seber, Adriana, Gouveia, Roseane V *, Bonfim, Carmem *, Simões, Belinda Pinto *, Nur, Erfan, Horn, Biljana N., Eckrich, Michael, Hanna, Rabi, Dhedin, Nathalie *, Almhareb, Fahed, Aljurf, Mahmoud, Rangarajan, Hemalatha G., Gatwood, Katie S. *, Orton, Lindsay *, Kitko, Carrie Lynn, Alzahrani, Mohsen *, Alahmari, Ali Debsan *, De La Fuente, Josu *, Kassim, Adetola A.
Zdroj:	In Blood 15 November 2022 140 Supplement 1:10462-10464
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu